JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB126736

Anti-GAMT antibody [EPR6925]

Be the first to review this product! Submit a review

|

(5 Publications)

Rabbit Recombinant Monoclonal GAMT antibody. Suitable for IHC-P, WB and reacts with Human samples. Cited in 5 publications.

View Alternative Names

Guanidinoacetate N-methyltransferase, GAMT

3 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GAMT antibody [EPR6925] (AB126736)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GAMT antibody [EPR6925] (AB126736)

ab126736 at 1/100 dilution staining GAMT in Formalin-fixed Paraffin-embedded Human liver tissue by Immunohistochemistry.

Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.

Western blot - Anti-GAMT antibody [EPR6925] (AB126736)
  • WB

Unknown

Western blot - Anti-GAMT antibody [EPR6925] (AB126736)

All lanes:

Western blot - Anti-GAMT antibody [EPR6925] (ab126736) at 1/1000 dilution

Lane 1:

Human fetal liver Lysate at 10 µg

Lane 2:

HepG2 lysate at 10 µg

Lane 3:

SH-SY5Y lysate at 10 µg

Secondary

All lanes:

Goat-anti-rabbit HRP at 1/2000 dilution

Predicted band size: 26 kDa

true

OI-RD Scanning - Anti-GAMT antibody [EPR6925] (AB126736)
  • OI-RD Scanning

Unknown

OI-RD Scanning - Anti-GAMT antibody [EPR6925] (AB126736)

We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.

  • Carrier free

    Anti-GAMT antibody [EPR6925] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR6925

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/250", "IHCP-species-notes": "<p></p>", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" }, "Rat": { "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Stable for 12 months at -20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Guanidinoacetate N-methyltransferase commonly known as GAMT catalyzes the conversion of guanidinoacetate to creatine through methylation. The enzyme has a molecular mass of approximately 24 kDa. GAMT is expressed in various body tissues with high levels observed in the liver and kidney. The enzyme plays an important role in the synthesis of creatine an important molecule for energy storage and supply in muscle tissues.
Biological function summary

GAMT participates in the final step of creatine biosynthesis. This enzyme acts independently rather than forming part of a larger complex. In the cells creatine serves as an energy buffer predominantly involved in tissues with high and fluctuating energy demands such as muscles and the brain. GAMT's activity ensures a steady supply of creatine which supports cellular energy homeostasis.

Pathways

GAMT plays a significant role in the creatine biosynthesis pathway. This pathway is vital for maintaining the energy balance in cells especially those with a high-energy requirement. GAMT directly interacts with guanidinoacetate as a substrate with S-adenosylmethionine serving as the methyl group donor. Additionally GAMT is connected to the arginine and proline metabolism pathway alongside other enzymes such as arginine-glycine amidinotransferase (AGAT) which acts earlier in the creatine biosynthetic pathway.

Mutations or deficiencies in GAMT associate with disorders such as GAMT deficiency which leads to creatine deficiency syndromes. This condition typically results in neurological impairments including developmental delays and cognitive dysfunctions. The disorder also relates to disrupted creatine production in which AGAT and other enzymes within the creatine biosynthetic pathway may contribute to similar phenotypic outcomes. Research into these connections aids in understanding the broader implications of GAMT dysfunction.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Converts guanidinoacetate to creatine, using S-adenosylmethionine as the methyl donor (PubMed : 24415674, PubMed : 26003046, PubMed : 26319512). Important in nervous system development (PubMed : 24415674).
See full target information Guanidinoacetate N-methyltransferase

Publications (5)

Recent publications for all applications. Explore the full list and refine your search

Journal of animal science and biotechnology 16:31 PubMed40022146

2025

Effects of dietary supplementation of creatine on fetal development in gilts at d 60 and d 90 of gestation.

Applications

Unspecified application

Species

Unspecified reactive species

Arianna N Lopez,Maddison A Olivarez,Claire Stenhouse,Robyn M Moses,Makenzie G Newton,Nirvay Sah,Heewon Seo,Joseph Cain,Carli Lefevre,Alexandria Ross,Patrick Ryan,Jeffrey G Wiegert,Guoyao Wu,Gregory A Johnson,Fuller W Bazer

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11:e2403517 PubMed39119937

2024

Creatine Promotes Endometriosis by Inducing Ferroptosis Resistance via Suppression of PrP.

Applications

Unspecified application

Species

Unspecified reactive species

Siman Chen,Xiaoqian Ma,Yukai Liu,Zhiqi Zhong,Chunyan Wei,Mingqing Li,Xiaoyong Zhu

Molecular therapy. Methods & clinical development 25:278-296 PubMed35505663

2022

Gene therapy for guanidinoacetate methyltransferase deficiency restores cerebral and myocardial creatine while resolving behavioral abnormalities.

Applications

Unspecified application

Species

Unspecified reactive species

Suhail Khoja,Jenna Lambert,Matthew Nitzahn,Adam Eliav,YuChen Zhang,Mikayla Tamboline,Colleen T Le,Eram Nasser,Yunfeng Li,Puja Patel,Irina Zhuravka,Lindsay M Lueptow,Ilona Tkachyova,Shili Xu,Itzhak Nissim,Andreas Schulze,Gerald S Lipshutz

Nutrients 13: PubMed34371916

2021

Creatine Monohydrate Supplementation Increases White Adipose Tissue Mitochondrial Markers in Male and Female Rats in a Depot Specific Manner.

Applications

Unspecified application

Species

Unspecified reactive species

Chantal R Ryan,Michael S Finch,Tyler C Dunham,Jensen E Murphy,Brian D Roy,Rebecca E K MacPherson

International journal of oncology 57:1368-1380 PubMed33174013

2020

Knockdown of eukaryotic translation initiation factor 5A2 enhances the therapeutic efficiency of doxorubicin in hepatocellular carcinoma cells by triggering lethal autophagy.

Applications

Unspecified application

Species

Unspecified reactive species

Yuexiao Tang,Ke Chen,Xiaorui Luan,Jinyan Zhang,Rongrong Liu,Xiaoxiao Zheng,Shangzhi Xie,Haiping Ke,Xianning Zhang,Wei Chen
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com